Aldeyra Therapeutics, Inc. — Form 8-K
Filed July 30, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Aldeyra signed a 3-year commercial lease for ~4,067 sq ft (Suite 23-1 Front, 23 Bradford Street, Concord, MA) commencing September 1, 2026 through September 30, 2029. Base rent: $12,201/month starting October 2026 after one month abatement, escalating to $12,540/month (11/1/2027) and $12,879/month (11/1/2028); total 3-year rent ~$451,440. Security deposit: $50,000. Build-out costs estimated at ~$53,000 (flooring $31,795 + installation $21,000), with lessor contributing $10,293 flooring credit and $1,000 electrical credit. Lessee responsible for 65% of shared first-floor utilities.
Why this rating
Routine office lease renewal/relocation. ~$451k over 3 years ≈0.2% of $232M market cap. Standard corporate occupancy agreement with no business impact.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.